X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

MYMD

Closed

Mymd Pharmaceuticals Inc

1.6
+0.3 (+22.56%)
Last Update: 25 Sep 2024 16:30:00
Yesterday: 1.33
Day's Range: 1.3101 - 1.739
Send
When Written:
 
1.51
MyMD Pharmaceuticals Inc is a clinical stage biopharmaceutical company that is focused on developing novel therapies for the treatment of autoimmune diseases, including multiple sclerosis (MS), rheumatoid arthritis (RA), and psoriasis. The company's lead product candidate is MYMD-1, a small molecule drug that has been shown to stimulate the production of regulatory T cells, which play a key role in controlling the immune system and preventing autoimmune diseases. MyMD Pharmaceuticals is also developing a pipeline of other drug candidates, including MYMD-2, which targets the treatment of inflammatory bowel disease (IBD), and MYMD-3, which targets the treatment of cancer. The company is headquartered in West Palm Beach, Florida and was founded in 2015.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X